Verschiedene Medikamente in Tablettenform (Symbolbild).
Quelle: © pixabay.com/CC0 www.pixabay.com
Google
neu
Die Newsartikel wurden besser lesbar gestaltet.
Mehr erfahren
 |  25. Oktober 2024, 16:15

BetterInvesting™ Magazine Update on Merck (MRK) and Ball (BALL)

PR Newswire

Anhören
Teilen
Feedback
Kopieren
ARIVA Newsletter
Ball Corp 49,66 $ Ball Corp Chart +0,16%
Merck & Co., inc. 85,10 $ Merck & Co., inc. Chart -0,67%

TROY, Mich., Oct. 25, 2024 /PRNewswire/ -- The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Merck & Co. (NYSE: MRK) as its "Stock to Study" and Ball Corp (NYSE: BALL) as its "Undervalued Stock" in the January 2025 issue for investors' informational and educational use.

The organization remains concerned about the number of Americans who are investing for the future. "Too many Americans hesitate to invest, waiting for what they believe is the perfect moment, such as after the election, or for other reasons, missing out on the benefits of compounding. With Halloween less than a week away, it's a reminder that those who take part, reap the rewards," said Ken Zendel, CEO of the National Association of Investors (NAIC), the parent organization of BetterInvesting.

To help investors get started, the National Association of Investors has launched a free eLearning course entitled Stock Investing Basics available for anyone who desires to learn at https://www.betterinvesting.org/learn-about-investing/elearning-courses

Explore the January 2025 issue of BetterInvesting Magazine for more education as well as details about the latest stocks recommended for study by the Editorial Advisory and Securities Review Committee. Non-members can utilize the limited, trial version of the BetterInvesting online stock selection and analysis tools to study the investment potential of both Merck & Co. as well as Ball Corp. by viewing their fundamental data and applying judgments.

Committee members are Daniel J. Boyle, CFA; Marisa Bradbury, CFA; Philip Keating, CFA; Walter J. Kirchberger, CFA; Anne Nichols, CFA; and Dan Rutter, CFA.

As stated, the BetterInvesting committee's Stock to Study and Undervalued Stock choices are for the informational and educational uses of investors. They are not to be considered as endorsed or recommended for purchase by NAIC/BetterInvesting. BetterInvesting urges investors to educate themselves about the stock market so they can make informed decisions about stock purchases.  Investors should conduct their own review and analysis of any company of interest using the Stock Selection Guide before making an investment decision.

About BetterInvesting:

BetterInvesting™, a national 501(c)(3) nonprofit, investment education organization, has been empowering everyday Americans since 1951. Also known as the National Association of Investors™ (NAIC®), we have helped more than 5 million people from all walks of life learn how to improve their financial future. BetterInvesting provides unbiased, in-depth investing education and powerful online stock analysis tools to create successful lifelong investors. BetterInvesting staff, along with a dedicated community of volunteers across America, teach the organization's principles and time-tested methodology to individuals and investment clubs. For more information about BetterInvesting, please visit www.betterinvesting.org

Follow us on LinkedInInstagram and Facebook.

Contact: 877-275-6242

Cision View original content:https://www.prnewswire.com/news-releases/betterinvesting-magazine-update-on-merck-mrk-and-ball-ball-302287661.html

SOURCE NAIC-BetterInvesting


Community-Beiträge zu Merck & Co., inc.

aus Forum-Thread: Merck & Co. (MRK) bricht um 30% ein
Avatar des Verfassers
04.02.2025 - 22:33 Uhr
Trimalchio
Das Problem...
... bei Merck scheint hier zu sein, dass bald schon Patente auslaufen, die für rund die Hälfte der Umsätze stehen;und das Management sich lieber auf Aktienrückkäufe zuwendet, statt die Pipeline für zukünftige Geschäfte zu füllen.Meine Position ist hier schon voll, aber ich bleibe drin.
Avatar des Verfassers
04.02.2025 - 21:16 Uhr
gdchs
Hab hier mal ein paar aufgesammelt,
was meint ihr zu den Zahlen und Aussichten ?
Jetzt anmelden und diskutieren Registrieren Login

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.